Who owns Onyx Pharmaceuticals Inc note 4.000% 8/1?

Key details on Onyx Pharmaceuticals Inc note 4.000% 8/1

Who owns Onyx Pharmaceuticals Inc note 4.000% 8/1?

Is Onyx Pharmaceuticals Inc note 4.000% 8/1 a good stock to own? Find out who bought Onyx Pharmaceuticals Inc note 4.000% 8/1, who sold Onyx Pharmaceuticals Inc note 4.000% 8/1 stock, and who holds a large position in Onyx Pharmaceuticals Inc note 4.000% 8/1.

Fund Name Number of Shares Share Valuation As Of
Deerfield Management Company 50.33M $63.42M March 31, 2012
Tenor Capital Management 40.38M $130.02M Sept. 30, 2013
D. E. Shaw & Co 35.58M $114.21M Sept. 30, 2013
Kohlberg Kravis Roberts & Co 32.88M $105.21M Sept. 30, 2013
WHITEBOX ADVISORS 23.85M $76.55M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 15.03M $48.11M Sept. 30, 2013
AQR Capital Management 11.88M $38.15M Sept. 30, 2013
Angelo, Gordon & Co 11.50M $36.80M Sept. 30, 2013
Geode Capital Management 11.50M $36.91M Sept. 30, 2013
CITADEL ADVISORS 10.00M $18.30M June 30, 2012
Symphony Asset Management 9.25M $21.09M June 30, 2013
Davidson Kempner Capital Management 9.00M $18.27M Dec. 31, 2012
UBS O'Connor 8.85M $20.23M June 30, 2013
Farallon Capital Management 8.04M $25.79M Sept. 30, 2013
Polar Securities 7.50M $24.07M Sept. 30, 2013
Visium Asset Management 7.00M $12.81M June 30, 2012
Glazer Capital 6.79M $21.92M Sept. 30, 2013
Camden Asset Management 5.39M $9.87M June 30, 2012
CALAMOS ADVISORS 5.00M $11.30M Sept. 30, 2012
Bank of America Corporation 4.80M $9.69M Dec. 31, 2012
Advent Capital Management 3.35M $6.80M June 30, 2012
Barclays 3.28M $10.49M Sept. 30, 2013
GOLDMAN SACHS 3.09M $5.63M June 30, 2012
Nicholas Investments Partners 2.75M $6.19M Sept. 30, 2012
GRACE BROTHERS MANAGEMENT 2.75M $6.19M Sept. 30, 2012
LORD, ABBETT & CO 2.64M $6.02M June 30, 2013
Palisade Capital Management 2.50M $5.70M June 30, 2013
Verition Fund Management 2.50M $5.65M Sept. 30, 2012
Royal Bank of Canada 2.11M $6.77M Sept. 30, 2013
HIGHBRIDGE CAPITAL MANAGEMENT 2.10M $6.73M Sept. 30, 2013
SSI Investment Management 2.05M $3.75M June 30, 2012
ClearBridge Advisors 2.00M $2.66M Dec. 31, 2011
Wells Fargo & Company 2.00M $6.40M Sept. 30, 2013
ClearBridge Asset Management 1.60M $1.87M May 12, 2011
ALLSTATE INSURANCE COMPANY 1.51M $1.81M Dec. 31, 2010
Raven Rock Capital Management 1.50M $3.52M March 31, 2013
PENN Capital Management 1.37M $3.12M June 30, 2013
Ameriprise Financial 1.20M $2.18M June 30, 2012
JPMORGAN CHASE & CO 1.20M $3.83M Sept. 30, 2013
Citi 1.10M $3.53M Sept. 30, 2013
------------------ --------------------------- ------------------------------ 1000000 $2.24M Sept. 30, 2012
Dinsmore Capital Management 1000000 $1.26M March 31, 2012
CNH Partners 1000000 $1.34M Dec. 31, 2011
Jefferies 899000 $2.09M March 31, 2013
Wolverine Asset Management 667000 $887110 Dec. 31, 2011
Allianz Asset Management AG 600000 $1.93M Sept. 30, 2013

Who sold Onyx Pharmaceuticals Inc note 4.000% 8/1?

Fund Name Date Sold Number of Shares Sold Share Valuation
Nomura Holdings Dec. 31, 2012 8.58M $17.32M
Oaktree Capital Management March 31, 2012 35.25M $44.41M
Credit Suisse AG Sept. 30, 2011 3.37M $3.81M
Zazove Associates Sept. 30, 2011 680000 $761600
Inves June 30, 2011 755000 $898450
Wellington Management Company June 30, 2011 635000 $762000
RWC Asset Management March 31, 2011 3.00M $3.51M
THE ALLSTATE CORPORATION Dec. 31, 2010 1.51M $1.81M